Proxymetacaine Hydrochloride
Alcaine contains the active substance proxymetacaine hydrochloride, which acts as a local anesthetic.
Alcaine is used for surface anesthesia before ophthalmic procedures that require rapid and short-term anesthesia, such as: preparation for cataract surgery, removal of corneal sutures, tonometric measurement of intraocular pressure, gonioscopic examination, removal of foreign bodies, scraping of the conjunctiva for diagnostic purposes, and other procedures where surface anesthesia is necessary.
Before starting treatment with Alcaine, discuss it with your doctor or pharmacist.
If hypersensitivity or irritation symptoms occur or worsen, consult a doctor immediately.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before using this medicine.
Using Alcaine during pregnancy and breastfeeding is not recommended.
After using Alcaine, temporary blurred vision may occur. Do not drive or operate machinery until this symptom has resolved.
The medicine contains 0.0035 mg of benzalkonium chloride in each drop, which corresponds to 0.1 mg/ml.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinserting. Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If abnormal sensations, stinging, or eye pain occur after using the medicine, consult a doctor.
Alcaine is intended for use by a doctor only.
Recommended dose
When preparing a patient for a simple examination, e.g., tonometric examination or other short-term procedures, usually one to two drops are instilled directly before the procedure.
Before minor surgical procedures, such as removal of a foreign body or sutures, instill one to two drops every five to ten minutes, one to three times.
To achieve long-term anesthesia, for example, during cataract surgery, instill one to two drops of the medicine into the eye (eyes) every five to ten minutes, three to five times.
Remember that the local anesthetic effect occurs within 30 seconds and may last up to 15 minutes.
Method of administration
Alcaine should only be instilled into the eye (eyes).
Remove the cap. If the protective collar is loose after removing the cap, discard it before using the medicine.
To prevent infection of the dropper tip or solution, be careful not to touch the dropper tip to the eyelids or surrounding tissues. Keep the bottle tightly closed when not in use.
The absorption of the medicine into the general circulation can be reduced by using the following methods after instillation:
Do not use the solution if it is cloudy or has changed color.
Note: Since there is no blinking reflex after using the medicine, it is recommended to apply an eye patch after the procedure.
If you are using other eye drops or ointments at the same time,wait at least 5 minutes between administrations of the different medicines. Apply eye ointments last.
In case of using a higher dose than recommended, flush the eye with lukewarm water.
In case of overdose or accidental ingestion, contact a doctor, pharmacist, or poison control center immediately, as severe reactions from the nervous or respiratory system may occur.
Do not double the dose to make up for a missed dose.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Alcaine can cause side effects, although not everybody gets them.
The following side effects have been observed with the use of Alcaine, but their frequency cannot be estimated from the available data:
Additionally, uncontrolled use or abuse of Alcaine may lead to permanent corneal disorders and (or) eye damage.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Protect from light.
Store in a refrigerator (2°C – 8°C).
Shelf life after first opening the bottle: 4 weeks.
After each use, close the bottle tightly.
Do not use this medicine after the expiry date stated on the packaging after: EXP.
The expiry date refers to the last day of the month.
Do not use this medicine if you notice clouding or a change in color.
Medicines should not be disposed of via wastewater. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Alcaine is available as a sterile, isotonic aqueous solution.
The LDPE bottle with a dropper contains 15 ml of solution.
Alcon Polska Sp. z o.o.
ul. Marynarska 15
02-674 Warsaw
tel.: (+48) 22 820 34 50
Alcon Laboratories Belgium
Lichterveld 3
2870 Puurs-Sint-Amands
Belgium
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.